Mounjaro vs Wegovy: What’s the Difference and Which Is Better for Weight Loss?

Mounjaro vs Wegovy: What’s the Difference and Which Is Better for Weight Loss?

If you’re comparing Mounjaro vs Wegovy, you’re looking at two highly effective medications designed to support weight management — but with very different mechanisms.

This TeleMedsForMe guide explains how they differ so you can choose with confidence.

What Is Mounjaro?

Mounjaro contains tirzepatide, which activates both GLP-1 and GIP receptors. This dual action leads to stronger appetite control and metabolic effects.

Mounjaro is FDA-approved for diabetes and used off-label for weight loss. Mounjaro vs Wegovy.

What Is Wegovy?

Wegovy contains semaglutide and is FDA-approved specifically for chronic weight management. It is the weight-loss labeled version of semaglutide.

Mounjaro vs Wegovy: Key Differences

Which Works Better for Weight Loss? Mounjaro vs Wegovy

Studies consistently show tirzepatide (Mounjaro) produces greater average weight loss than semaglutide (Wegovy), but Wegovy remains extremely effective. Mounjaro vs Wegovy

Side Effects -Mounjaro vs Wegovy

Both medications share similar side effects, including nausea, vomiting, constipation, and fatigue. Mounjaro may feel stronger early due to its dual action.

Which Do Doctors Prefer?

Wegovy is widely used due to FDA weight-loss labeling.

Mounjaro is increasingly preferred for stronger results when patients tolerate it well.

Who Should Choose Wegovy? Mounjaro vs Wegovy

• Prefer FDA weight-loss labeling

• Good response to semaglutide

• Insurance coverage available

Who Should Choose Mounjaro?

• Want maximum weight-loss potential

• Have insulin resistance

• Limited response to semaglutide

TeleMedsForMe Advantage

TeleMedsForMe helps you compare licensed providers offering both Mounjaro and Wegovy programs so you can choose safely and responsibly. Mounjaro vs Wegovy